henhaobio
Sign in

bioRxivImmunologyPreprint

Regulatory T cells control type 1-driven immunopathology restraining GM-CSF-producing helper T cells

S. Costa-Pereira, M. Lanzinger, M. Andreadou, N. Nunez, J. Villar-Vesga, F. Prisco, P. Hane, E. Roussel, S. Krishnarajah, R. C. Lindemann, F. Westermann, L. Oberbichler, A. Sethi, A. Fonseca, M. Pinzger, S. Tugues, S. Mundt, A. Kipar, M. Greter, D. De Feo, B. Becher

PDFDOI

Abstract

Regulatory T (Treg) cells are critical for maintaining peripheral tolerance and preventing autoimmunity. Treg cell depletion or dysfunction rapidly results in fatal multiorgan inflammation linked to unrestrained effector T cell expansion, but the cytokine network underlying immunopathology, and its direct cellular mediators, remain elusive. Here, we combined gene targeting, fate-mapping tools, and high-dimensional cytometry to identify the T helper (TH) cell-derived cytokines and responding cells that execute inflammatory tissue damage upon global loss of peripheral tolerance in mice. We found that TH cell-derived GM-CSF, but not IL-17A, directed the ensuing immunopathology and thereby mortality through recruitment of tissue-invading phagocytes and granulocytes, and enhancement of their reactive oxygen species production and phagocytic proficiency. Our study highlights the critical role of Treg cells in controlling GM-CSF- producing TH cells and type 1-responses to restrain phagocyte-mediated tissue destruction and provides a framework for the use of anti-GM-CSF therapies in patients with chronic inflammatory disorders.

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.